PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.\', \'Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.\', \'State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Vaccine Research Center, National Institutes of Health, Bethesda, USA.\', \'Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.\', \'Division of Infectious Diseases, Department of Internal Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/22221751.2021.2011623
?:doi
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 34836485
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all